References
- Aaron J, Choi Y. (2000). Bone versus immune system. Nature, 408, 535–6
- D’Amelio P. (2013). The immune system and postmenopausal osteoporosis. Immunol Invest, 42, 544–54
- Dewhirst FE, Stashenko PP, Mole JE, Tsurumachi T. (1985). Purification and partial sequence of human osteoclast-activating factor: Identity with interleukin 1 beta. J Immunol, 135, 2582–8
- Dziak R. (2013). The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells. Immun Invest, 42, 510–18
- Dziak R, Brand JS. (1974). Calcium transport in isolated bone cells I. Bone cell isolation procedures. J Cell Physiol, 84, 75–83
- Horton JE, Raisz LG, Simmons HA, et al. (1972). Bone resorbing activity in supernatant fluid from cultured human peripheral bllod leukocytes. Science, 177, 793–5
- Horwood NJ. (2013). Immune cells and bone: Coupling goes both ways. Immun Invest, 42, 532–43
- McSheehy PMJ, Chambers TJ. (1986). Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology, 118, 824–8
- Myneni SR, Settem RP, Sharma A. (2013). Bacteria take control of Tolls and T cells to destruct jaw-bone. Immun Invest, 42, 519–31
- Peck WA, Birge SJ, Fedak SA. (1964). Bone cells: biochemical and biological studies after enzymatic isolation. Science, 146 (3650), 1476–7
- Souza PPC, Lerner UH. (2013). The role of cytokines in inflammatory bone loss. Immun Invest, 42, 555–622
- Wong BR, Josien R, Lee SY, et al. (1997a). TRANCE, a new tumor necrosis factor (TNF) family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med, 186, 1–6
- Wong BR, Rho J, Arron J, et al. (1997b). TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem, 272, 25190–4
- Wong G, Cohn DV. (1974). Separation of parathyroid hormone and calcitonin-sensitive cells from non-responsive bone cells. Nature, 252, 713–15